HEADER TRANSFERASE 14-JUL-04 1U0V TITLE AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES CYCLIZATION TITLE 2 OF SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES: 18XCHS STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CHALCONE SYNTHASE 2; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NARINGENIN-CHALCONE SYNTHASE 2; COMPND 5 EC: 2.3.1.74; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MEDICAGO SATIVA; SOURCE 3 ORGANISM_TAXID: 3879; SOURCE 4 GENE: CHS2; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHIS8 KEYWDS TYPE III POLYKETIDE SYNTHASE, PKS, CONDENSING ENZYME, THIOLASE FOLD, KEYWDS 2 ALPHA-BETA-ALPHA-BETA-ALPHA FOLD, ALDOL SWITCH, CATALYTIC TRIAD, KEYWDS 3 ENGINEERED RESVERATROL SYNTHASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR M.B.AUSTIN,M.E.BOWMAN,J.-L.FERRER,J.SCHRODER,J.P.NOEL REVDAT 5 23-AUG-23 1U0V 1 REMARK REVDAT 4 27-OCT-21 1U0V 1 SEQADV REVDAT 3 11-OCT-17 1U0V 1 REMARK REVDAT 2 24-FEB-09 1U0V 1 VERSN REVDAT 1 12-OCT-04 1U0V 0 JRNL AUTH M.B.AUSTIN,M.E.BOWMAN,J.-L.FERRER,J.SCHRODER,J.P.NOEL JRNL TITL AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES JRNL TITL 2 CYCLIZATION SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES JRNL REF CHEM.BIOL. V. 11 1179 2004 JRNL REFN ISSN 1074-5521 JRNL PMID 15380179 JRNL DOI 10.1016/J.CHEMBIOL.2004.05.024 REMARK 2 REMARK 2 RESOLUTION. 1.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.93 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1532315.570 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 52432 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2639 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8245 REMARK 3 BIN R VALUE (WORKING SET) : 0.2140 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 445 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.012 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5881 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 716 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 12.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 20.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.15000 REMARK 3 B22 (A**2) : -2.71000 REMARK 3 B33 (A**2) : 4.86000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.40000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.20 REMARK 3 ESD FROM SIGMAA (A) : 0.12 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.25 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.17 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.810 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 0.720 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 1.170 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.000 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 1.520 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 67.03 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : CISGLY_18X.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1U0V COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-AUG-04. REMARK 100 THE DEPOSITION ID IS D_1000023105. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-NOV-00 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : DIAMOND REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : PRODC REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52432 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900 REMARK 200 RESOLUTION RANGE LOW (A) : 24.930 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.00 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: 1BI5 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, AMMONIUM ACETATE, HEPES-NA+ REMARK 280 BUFFER, ETHYLENE GLYCOL, DTT, PH 7.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.87650 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAINS A AND B CONSTITUTE THE BIOLOGICAL HOMODIMER. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5370 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -12.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 SER A -2 REMARK 465 HIS A -1 REMARK 465 GLY A 0 REMARK 465 MET A 1 REMARK 465 GLY B -3 REMARK 465 SER B -2 REMARK 465 HIS B -1 REMARK 465 GLY B 0 REMARK 465 MET B 1 REMARK 465 VAL B 2 REMARK 465 SER B 3 REMARK 465 VAL B 4 REMARK 465 SER B 5 REMARK 465 GLU B 6 REMARK 465 ILE B 7 REMARK 465 ARG B 8 REMARK 465 LYS B 9 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 268 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 89 108.44 -53.71 REMARK 500 SER A 90 8.44 -152.82 REMARK 500 GLU A 231 -5.33 65.85 REMARK 500 MET A 337 31.40 -98.14 REMARK 500 SER A 338 -132.50 52.27 REMARK 500 LEU A 377 76.74 12.01 REMARK 500 THR B 50 -47.17 -3.93 REMARK 500 SER B 90 8.33 -152.56 REMARK 500 THR B 194 4.90 -69.26 REMARK 500 THR B 204 -65.05 -92.87 REMARK 500 GLU B 231 -42.15 70.10 REMARK 500 MET B 337 31.90 -95.46 REMARK 500 SER B 338 -131.21 52.27 REMARK 500 LEU B 377 70.83 30.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1U0W RELATED DB: PDB REMARK 900 AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES REMARK 900 CYCLIZATION SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES: 18XCHS+ REMARK 900 RESVERATROL STRUCTURE REMARK 900 RELATED ID: 1U0U RELATED DB: PDB REMARK 900 AN ALDOL SWITCH DISCOVERED IN STILBENE SYNTHASES MEDIATES REMARK 900 CYCLIZATION SPECIFICITY OF TYPE III POLYKETIDE SYNTHASES: PINE REMARK 900 STILBENE SYNTHASE STRUCTURE REMARK 900 RELATED ID: 1BI5 RELATED DB: PDB REMARK 900 THE PRIOR WILD TYPE ALFALFA CHS STRUCTURE DBREF 1U0V A 1 389 UNP P30074 CHS2_MEDSA 1 389 DBREF 1U0V B 1 389 UNP P30074 CHS2_MEDSA 1 389 SEQADV 1U0V GLY A -3 UNP P30074 CLONING ARTIFACT SEQADV 1U0V SER A -2 UNP P30074 CLONING ARTIFACT SEQADV 1U0V HIS A -1 UNP P30074 CLONING ARTIFACT SEQADV 1U0V GLY A 0 UNP P30074 CLONING ARTIFACT SEQADV 1U0V ALA A 96 UNP P30074 ASP 96 ENGINEERED MUTATION SEQADV 1U0V LEU A 98 UNP P30074 VAL 98 ENGINEERED MUTATION SEQADV 1U0V ALA A 99 UNP P30074 VAL 99 ENGINEERED MUTATION SEQADV 1U0V MET A 100 UNP P30074 VAL 100 ENGINEERED MUTATION SEQADV 1U0V SER A 131 UNP P30074 THR 131 ENGINEERED MUTATION SEQADV 1U0V THR A 133 UNP P30074 SER 133 ENGINEERED MUTATION SEQADV 1U0V THR A 134 UNP P30074 GLY 134 ENGINEERED MUTATION SEQADV 1U0V PRO A 135 UNP P30074 VAL 135 ENGINEERED MUTATION SEQADV 1U0V LEU A 137 UNP P30074 MET 137 ENGINEERED MUTATION SEQADV 1U0V VAL A 157 UNP P30074 TYR 157 ENGINEERED MUTATION SEQADV 1U0V GLY A 158 UNP P30074 MET 158 ENGINEERED MUTATION SEQADV 1U0V VAL A 159 UNP P30074 MET 159 ENGINEERED MUTATION SEQADV 1U0V PHE A 160 UNP P30074 TYR 160 ENGINEERED MUTATION SEQADV 1U0V HIS A 162 UNP P30074 GLN 162 ENGINEERED MUTATION SEQADV 1U0V LYS A 268 UNP P30074 LEU 268 ENGINEERED MUTATION SEQADV 1U0V GLY A 269 UNP P30074 LYS 269 ENGINEERED MUTATION SEQADV 1U0V ALA A 270 UNP P30074 ASP 270 ENGINEERED MUTATION SEQADV 1U0V ASP A 273 UNP P30074 GLY 273 ENGINEERED MUTATION SEQADV 1U0V GLY B -3 UNP P30074 CLONING ARTIFACT SEQADV 1U0V SER B -2 UNP P30074 CLONING ARTIFACT SEQADV 1U0V HIS B -1 UNP P30074 CLONING ARTIFACT SEQADV 1U0V GLY B 0 UNP P30074 CLONING ARTIFACT SEQADV 1U0V ALA B 96 UNP P30074 ASP 96 ENGINEERED MUTATION SEQADV 1U0V LEU B 98 UNP P30074 VAL 98 ENGINEERED MUTATION SEQADV 1U0V ALA B 99 UNP P30074 VAL 99 ENGINEERED MUTATION SEQADV 1U0V MET B 100 UNP P30074 VAL 100 ENGINEERED MUTATION SEQADV 1U0V SER B 131 UNP P30074 THR 131 ENGINEERED MUTATION SEQADV 1U0V THR B 133 UNP P30074 SER 133 ENGINEERED MUTATION SEQADV 1U0V THR B 134 UNP P30074 GLY 134 ENGINEERED MUTATION SEQADV 1U0V PRO B 135 UNP P30074 VAL 135 ENGINEERED MUTATION SEQADV 1U0V LEU B 137 UNP P30074 MET 137 ENGINEERED MUTATION SEQADV 1U0V VAL B 157 UNP P30074 TYR 157 ENGINEERED MUTATION SEQADV 1U0V GLY B 158 UNP P30074 MET 158 ENGINEERED MUTATION SEQADV 1U0V VAL B 159 UNP P30074 MET 159 ENGINEERED MUTATION SEQADV 1U0V PHE B 160 UNP P30074 TYR 160 ENGINEERED MUTATION SEQADV 1U0V HIS B 162 UNP P30074 GLN 162 ENGINEERED MUTATION SEQADV 1U0V LYS B 268 UNP P30074 LEU 268 ENGINEERED MUTATION SEQADV 1U0V GLY B 269 UNP P30074 LYS 269 ENGINEERED MUTATION SEQADV 1U0V ALA B 270 UNP P30074 ASP 270 ENGINEERED MUTATION SEQADV 1U0V ASP B 273 UNP P30074 GLY 273 ENGINEERED MUTATION SEQRES 1 A 393 GLY SER HIS GLY MET VAL SER VAL SER GLU ILE ARG LYS SEQRES 2 A 393 ALA GLN ARG ALA GLU GLY PRO ALA THR ILE LEU ALA ILE SEQRES 3 A 393 GLY THR ALA ASN PRO ALA ASN CYS VAL GLU GLN SER THR SEQRES 4 A 393 TYR PRO ASP PHE TYR PHE LYS ILE THR ASN SER GLU HIS SEQRES 5 A 393 LYS THR GLU LEU LYS GLU LYS PHE GLN ARG MET CYS ASP SEQRES 6 A 393 LYS SER MET ILE LYS ARG ARG TYR MET TYR LEU THR GLU SEQRES 7 A 393 GLU ILE LEU LYS GLU ASN PRO ASN VAL CYS GLU TYR MET SEQRES 8 A 393 ALA PRO SER LEU ASP ALA ARG GLN ALA MET LEU ALA MET SEQRES 9 A 393 GLU VAL PRO ARG LEU GLY LYS GLU ALA ALA VAL LYS ALA SEQRES 10 A 393 ILE LYS GLU TRP GLY GLN PRO LYS SER LYS ILE THR HIS SEQRES 11 A 393 LEU ILE VAL CYS SER THR THR THR PRO ASP LEU PRO GLY SEQRES 12 A 393 ALA ASP TYR GLN LEU THR LYS LEU LEU GLY LEU ARG PRO SEQRES 13 A 393 TYR VAL LYS ARG VAL GLY VAL PHE GLN HIS GLY CYS PHE SEQRES 14 A 393 ALA GLY GLY THR VAL LEU ARG LEU ALA LYS ASP LEU ALA SEQRES 15 A 393 GLU ASN ASN LYS GLY ALA ARG VAL LEU VAL VAL CYS SER SEQRES 16 A 393 GLU VAL THR ALA VAL THR PHE ARG GLY PRO SER ASP THR SEQRES 17 A 393 HIS LEU ASP SER LEU VAL GLY GLN ALA LEU PHE GLY ASP SEQRES 18 A 393 GLY ALA ALA ALA LEU ILE VAL GLY SER ASP PRO VAL PRO SEQRES 19 A 393 GLU ILE GLU LYS PRO ILE PHE GLU MET VAL TRP THR ALA SEQRES 20 A 393 GLN THR ILE ALA PRO ASP SER GLU GLY ALA ILE ASP GLY SEQRES 21 A 393 HIS LEU ARG GLU ALA GLY LEU THR PHE HIS LEU LYS GLY SEQRES 22 A 393 ALA VAL PRO ASP ILE VAL SER LYS ASN ILE THR LYS ALA SEQRES 23 A 393 LEU VAL GLU ALA PHE GLU PRO LEU GLY ILE SER ASP TYR SEQRES 24 A 393 ASN SER ILE PHE TRP ILE ALA HIS PRO GLY GLY PRO ALA SEQRES 25 A 393 ILE LEU ASP GLN VAL GLU GLN LYS LEU ALA LEU LYS PRO SEQRES 26 A 393 GLU LYS MET ASN ALA THR ARG GLU VAL LEU SER GLU TYR SEQRES 27 A 393 GLY ASN MET SER SER ALA CYS VAL LEU PHE ILE LEU ASP SEQRES 28 A 393 GLU MET ARG LYS LYS SER THR GLN ASN GLY LEU LYS THR SEQRES 29 A 393 THR GLY GLU GLY LEU GLU TRP GLY VAL LEU PHE GLY PHE SEQRES 30 A 393 GLY PRO GLY LEU THR ILE GLU THR VAL VAL LEU ARG SER SEQRES 31 A 393 VAL ALA ILE SEQRES 1 B 393 GLY SER HIS GLY MET VAL SER VAL SER GLU ILE ARG LYS SEQRES 2 B 393 ALA GLN ARG ALA GLU GLY PRO ALA THR ILE LEU ALA ILE SEQRES 3 B 393 GLY THR ALA ASN PRO ALA ASN CYS VAL GLU GLN SER THR SEQRES 4 B 393 TYR PRO ASP PHE TYR PHE LYS ILE THR ASN SER GLU HIS SEQRES 5 B 393 LYS THR GLU LEU LYS GLU LYS PHE GLN ARG MET CYS ASP SEQRES 6 B 393 LYS SER MET ILE LYS ARG ARG TYR MET TYR LEU THR GLU SEQRES 7 B 393 GLU ILE LEU LYS GLU ASN PRO ASN VAL CYS GLU TYR MET SEQRES 8 B 393 ALA PRO SER LEU ASP ALA ARG GLN ALA MET LEU ALA MET SEQRES 9 B 393 GLU VAL PRO ARG LEU GLY LYS GLU ALA ALA VAL LYS ALA SEQRES 10 B 393 ILE LYS GLU TRP GLY GLN PRO LYS SER LYS ILE THR HIS SEQRES 11 B 393 LEU ILE VAL CYS SER THR THR THR PRO ASP LEU PRO GLY SEQRES 12 B 393 ALA ASP TYR GLN LEU THR LYS LEU LEU GLY LEU ARG PRO SEQRES 13 B 393 TYR VAL LYS ARG VAL GLY VAL PHE GLN HIS GLY CYS PHE SEQRES 14 B 393 ALA GLY GLY THR VAL LEU ARG LEU ALA LYS ASP LEU ALA SEQRES 15 B 393 GLU ASN ASN LYS GLY ALA ARG VAL LEU VAL VAL CYS SER SEQRES 16 B 393 GLU VAL THR ALA VAL THR PHE ARG GLY PRO SER ASP THR SEQRES 17 B 393 HIS LEU ASP SER LEU VAL GLY GLN ALA LEU PHE GLY ASP SEQRES 18 B 393 GLY ALA ALA ALA LEU ILE VAL GLY SER ASP PRO VAL PRO SEQRES 19 B 393 GLU ILE GLU LYS PRO ILE PHE GLU MET VAL TRP THR ALA SEQRES 20 B 393 GLN THR ILE ALA PRO ASP SER GLU GLY ALA ILE ASP GLY SEQRES 21 B 393 HIS LEU ARG GLU ALA GLY LEU THR PHE HIS LEU LYS GLY SEQRES 22 B 393 ALA VAL PRO ASP ILE VAL SER LYS ASN ILE THR LYS ALA SEQRES 23 B 393 LEU VAL GLU ALA PHE GLU PRO LEU GLY ILE SER ASP TYR SEQRES 24 B 393 ASN SER ILE PHE TRP ILE ALA HIS PRO GLY GLY PRO ALA SEQRES 25 B 393 ILE LEU ASP GLN VAL GLU GLN LYS LEU ALA LEU LYS PRO SEQRES 26 B 393 GLU LYS MET ASN ALA THR ARG GLU VAL LEU SER GLU TYR SEQRES 27 B 393 GLY ASN MET SER SER ALA CYS VAL LEU PHE ILE LEU ASP SEQRES 28 B 393 GLU MET ARG LYS LYS SER THR GLN ASN GLY LEU LYS THR SEQRES 29 B 393 THR GLY GLU GLY LEU GLU TRP GLY VAL LEU PHE GLY PHE SEQRES 30 B 393 GLY PRO GLY LEU THR ILE GLU THR VAL VAL LEU ARG SER SEQRES 31 B 393 VAL ALA ILE FORMUL 3 HOH *716(H2 O) HELIX 1 1 SER A 3 ARG A 12 1 10 HELIX 2 2 THR A 35 THR A 44 1 10 HELIX 3 3 LYS A 49 LYS A 62 1 14 HELIX 4 4 THR A 73 ASN A 80 1 8 HELIX 5 5 PRO A 81 GLU A 85 5 5 HELIX 6 6 SER A 90 GLY A 118 1 29 HELIX 7 7 PRO A 120 ILE A 124 5 5 HELIX 8 8 GLY A 139 GLY A 149 1 11 HELIX 9 9 PHE A 165 ASN A 180 1 16 HELIX 10 10 VAL A 193 THR A 197 5 5 HELIX 11 11 HIS A 205 PHE A 215 1 11 HELIX 12 12 ALA A 270 GLU A 288 1 19 HELIX 13 13 ASP A 294 ILE A 298 5 5 HELIX 14 14 GLY A 306 LEU A 317 1 12 HELIX 15 15 LYS A 320 LYS A 323 5 4 HELIX 16 16 MET A 324 GLY A 335 1 12 HELIX 17 17 MET A 337 SER A 339 5 3 HELIX 18 18 ALA A 340 ASN A 356 1 17 HELIX 19 19 THR B 35 THR B 44 1 10 HELIX 20 20 LYS B 49 SER B 63 1 15 HELIX 21 21 THR B 73 ASN B 80 1 8 HELIX 22 22 ASN B 80 GLU B 85 1 6 HELIX 23 23 SER B 90 GLY B 118 1 29 HELIX 24 24 PRO B 120 ILE B 124 5 5 HELIX 25 25 GLY B 139 GLY B 149 1 11 HELIX 26 26 PHE B 165 ASN B 180 1 16 HELIX 27 27 VAL B 193 THR B 197 5 5 HELIX 28 28 LEU B 206 PHE B 215 1 10 HELIX 29 29 ALA B 270 GLU B 288 1 19 HELIX 30 30 PRO B 289 GLY B 291 5 3 HELIX 31 31 GLY B 306 ALA B 318 1 13 HELIX 32 32 LYS B 320 LYS B 323 5 4 HELIX 33 33 MET B 324 GLY B 335 1 12 HELIX 34 34 MET B 337 SER B 339 5 3 HELIX 35 35 ALA B 340 ASN B 356 1 17 SHEET 1 A 9 LYS A 155 PHE A 160 0 SHEET 2 A 9 HIS A 126 SER A 131 1 N VAL A 129 O VAL A 159 SHEET 3 A 9 ARG A 185 GLU A 192 1 O VAL A 189 N CYS A 130 SHEET 4 A 9 GLY A 218 GLY A 225 -1 O VAL A 224 N VAL A 186 SHEET 5 A 9 THR A 18 ALA A 25 -1 N LEU A 20 O ILE A 223 SHEET 6 A 9 PHE A 237 ILE A 246 -1 O PHE A 237 N ILE A 19 SHEET 7 A 9 THR A 378 SER A 386 -1 O VAL A 383 N TRP A 241 SHEET 8 A 9 TRP A 367 GLY A 374 -1 N GLY A 368 O LEU A 384 SHEET 9 A 9 PHE A 299 ALA A 302 1 N ILE A 301 O PHE A 371 SHEET 1 B 2 CYS A 30 GLU A 32 0 SHEET 2 B 2 ARG A 67 TYR A 69 -1 O ARG A 68 N VAL A 31 SHEET 1 C 3 ASP A 136 LEU A 137 0 SHEET 2 C 3 ILE B 254 ARG B 259 -1 O GLY B 256 N LEU A 137 SHEET 3 C 3 GLY B 262 LEU B 267 -1 O HIS B 266 N ASP B 255 SHEET 1 D 3 GLY A 262 LEU A 267 0 SHEET 2 D 3 ILE A 254 ARG A 259 -1 N ASP A 255 O HIS A 266 SHEET 3 D 3 ASP B 136 LEU B 137 -1 O LEU B 137 N GLY A 256 SHEET 1 E 9 LYS B 155 PHE B 160 0 SHEET 2 E 9 HIS B 126 SER B 131 1 N VAL B 129 O VAL B 159 SHEET 3 E 9 ARG B 185 GLU B 192 1 O VAL B 189 N CYS B 130 SHEET 4 E 9 GLY B 218 GLY B 225 -1 O VAL B 224 N VAL B 186 SHEET 5 E 9 THR B 18 ALA B 25 -1 N GLY B 23 O ALA B 221 SHEET 6 E 9 PHE B 237 ILE B 246 -1 O PHE B 237 N ILE B 19 SHEET 7 E 9 THR B 378 SER B 386 -1 O THR B 381 N ALA B 243 SHEET 8 E 9 TRP B 367 GLY B 374 -1 N GLY B 372 O GLU B 380 SHEET 9 E 9 PHE B 299 ALA B 302 1 N PHE B 299 O VAL B 369 SHEET 1 F 2 CYS B 30 GLU B 32 0 SHEET 2 F 2 ARG B 67 TYR B 69 -1 O ARG B 68 N VAL B 31 CISPEP 1 LEU A 137 PRO A 138 0 -0.03 CISPEP 2 LEU B 137 PRO B 138 0 0.35 CRYST1 71.638 59.753 82.539 90.00 108.17 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013959 0.000000 0.004580 0.00000 SCALE2 0.000000 0.016736 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012751 0.00000